Insider trade

Officer sold ~$364K of VRTX shares in the open market

Traded Jun 1, 2026 · Filed Jun 3, 2026

~$364K
Reported value · 828 sh @ $439.91: 20K
Holds after · shares reported: +15.6%
stock since the trade · S&P 500 +0.7%, $438.40 → $506.74 on Oct 1

Why it stands out

Vertex Pharmaceuticals's and Chief Legal Officer sold $364K of Vertex Pharmaceuticals shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Jun 1, 2026
Reporting period: Not applicable
Filed with the SEC: Jun 3, 2026

Officer$100K–$500KPre-arranged plan referenced

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$364,245

Shares × reported transaction price

Timing vs results

28 days after results of May 4, 2026, 63 days before results of Aug 3, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $438.40 on Jun 1, 2026, 20% above its 52-week low and 12% below its high, little changed over the previous 30 trading days

52-week range $366.54 (Aug 8, 2025) to $499.17 (Mar 10, 2026), 54% of the way up, from 251 adjusted closes. 30 trading days earlier: $441.20 on Apr 17, 2026. Describes the past only, not a forecast

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

After it was reported

After	Stock	S&P 500	Difference
7 days	+0.8%	-2.5%	+3.3%
30 days	+19.9%	-0.8%	+20.7%
90 days	+26.0%	+1.1%	+25.0%

Past results only. Not a forecast.

Source receipt

Record ID: 0000875320-26-000230
Filed / recorded: Jun 3, 2026, 8:06 PM UTC
Added to OQRO: Oct 2, 2026, 12:28 PM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: VERTEX PHARMACEUTICALS INC / MA
Issuer CIK: 875320
Ticker: VRTX
Reporting person: Joy Liu
Relationship: Officer
Officer title: EVP and Chief Legal Officer
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: Jun 1, 2026
Transaction code: S
Shares / units: 828
Price per share: $439.91
Acquired / disposed: Disposed (D)
Shares owned after: 19,959
Ownership form: Direct
Amendment: No

Footnotes from the filing

Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1, which was entered into on 11/25/2025.

Around the same time

Officer sold ~$288K of Vertex Pharmaceuticals

Scheduled in advance3mo ago

Officer sold ~$471K of Vertex Pharmaceuticals

Scheduled in advance3mo ago

Officer sold ~$1.83M of Vertex Pharmaceuticals

Scheduled in advance4mo ago